Revvity Inc
NYSE:RVTY

  • LAST PRICE
    122.4700
  • TODAY'S CHANGE (%)
    -1.5300 (-1.2339%)
  • Bid / Lots
    119.6000/ 1
  • Ask / Lots
    124.0600/ 5
  • Open / Previous Close
    123.1700 / 124.0000
  • Day Range
    118.9800
    123.9700
  • 52 Week Range
    82.1700
    129.5000
  • Volume
    999,722

Search Criteria

Click on magnifying glass icon to search

CompanyCountrySymbol

Charts

Price Comparison Graph. See accessible table below
Data delayed at least 15 minutes.

Advanced Medical Equipment Industry Peers

CompanyMarket CapP/E Ratio (TTM)EPS Growth (5yr)
RVTY
Revvity Inc
14.9B
58.5x
-7.39%
BRKR
Bruker Corp
8.7B
27.8x
+20.48%
WAT
Waters Corp
22.8B
36.7x
+7.16%
HOLX
Hologic Inc
18.3B
23.7x
---
QDEL
QuidelOrtho Corp
2.9B
-1.6x
---
ITGR
Integer Holdings Corp
4.6B
42.2x
+8.57%
As of 2024-11-10

Company Information

Revvity, Inc. is a provider of health science solutions, technologies, and services, which delivers workflows from discovery to development, and diagnosis to cure. Its segments include Life Sciences and Diagnostics. The Life Sciences segment provides products and services targeted towards the life sciences market. The Life Sciences Segment applications include MicroBeta, The MuviCyte live-cell imaging system, The Signals Image Artist, The VICTOR Nivo multimode plate reader benchtop system, The EnSight multimode plate reader benchtop system, BioLegend LEGENDplex bead-based reagents, and The Quantum GX2 system. Its Diagnostics segment develops diagnostics, tools, and applications focused on clinically oriented customers, within the reproductive health, immunodiagnostics, and applied genomics markets. It offers instruments, reagents, assay platforms and software to hospitals, and medical labs. It is focused on reproductive health, immunodiagnostics, and emerging market diagnostics.

Contact Information

Headquarters
77 4Th AvenueWALTHAM, MA, United States 02451
Phone
781-663-6900
Fax
---

Executives

Independent Non-Executive Chairman of the Board
Alexandros Michas
President, Chief Executive Officer, Director
Prahlad Singh
Chief Financial Officer, Senior Vice President
Maxwell Krakowiak
Senior Vice President - Administration, General Counsel, Secretary
Joel Goldberg
Senior Vice President - Strategy and Business Development
Daniel Tereau

Ratings

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

Reports

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals

Market Cap
$14.9B
Revenue (TTM)
$2.7B
Shares Outstanding
121.7M
Dividend Yield
0.23%
Annual Dividend Rate
0.2800 USD
Ex-Dividend Date
01-17-25
Pay Date
02-07-25
Beta
1.05
EPS
$2.09
Book Value
$63.79
P/E Ratio
58.5x
Price/Sales (TTM)
5.5
Price/Cash Flow (TTM)
21.7x
Operating Margin
11.21%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Calendar

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.